Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study

被引：9
作者：
Overcast, Wynton B. [1 ]
Zhang, Jianying [2 ]
Zynger, Debra L. [3 ]
Tozbikian, Gary H. [3 ]
机构：
[1] Ohio State Univ, Coll Med, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, 320 Lincoln Tower,1800 Cannon Dr, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Wexner Med Ctr, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷 / 02期
关键词：
ASCO/CAP guidelines; Breast cancer; Equivocal category; HER2 immunohistochemistry (IHC); HER2 fluorescence in situ hybridization (FISH); IN-SITU HYBRIDIZATION; POLYMERASE CHAIN-REACTION; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; COPY NUMBER; CANCER; RECEPTOR; IMMUNOHISTOCHEMISTRY; TRASTUZUMAB; FISH;
D O I：
10.1007/s00428-016-1951-8
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 212
页数：10
相关论文
共 50 条
  • [41] HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
    Kurozumi, Sasagu
    Padilla, Mary
    Kurosumi, Masafumi
    Matsumoto, Hiroshi
    Inoue, Kenichi
    Horiguchi, Jun
    Takeyoshi, Izumi
    Oyama, Tetsunari
    Ranger-Moore, Jim
    Allred, D. Craig
    Dennis, Eslie
    Nitta, Hiroaki
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 99 - 111
  • [42] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [43] Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
    Kamaljeet Singh
    Umadevi Tantravahi
    Michele M. Lomme
    Terese Pasquariello
    Margaret Steinhoff
    C. James Sung
    Breast Cancer Research and Treatment, 2016, 157 : 405 - 411
  • [44] FISH and HER2/neu equivocal immunohistochemistry in breast carcinoma
    Okaly, Geeta Vikram Patil
    Panwar, Dipti
    Lingappa, Kavitha Bidadli
    Kumari, Prasanna
    Anand, Abhishek
    Kumar, Prashantha
    Chikkalingaiah, Manju Hosur
    Kumar, Rekha Vijay
    INDIAN JOURNAL OF CANCER, 2019, 56 (02) : 119 - 123
  • [45] The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice
    Rakha, Emad A.
    Starczynski, Jane
    Lee, Andrew H. S.
    Ellis, Ian O.
    HISTOPATHOLOGY, 2014, 64 (05) : 609 - 615
  • [46] HER2 testing: ASCO/CAP guidelines and beyond implications for South Africa
    Nayler, S. J.
    SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 2 (01) : 7 - 12
  • [47] New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers
    N. Tchrakian
    L. Flanagan
    J. Harford
    J. M. Gannon
    C. M. Quinn
    Virchows Archiv, 2016, 468 : 207 - 211
  • [48] The impact of 2018 ASCO-CAP HER2 testing guidelines on breast cancer HER2 results. An audit of 2132 consecutive cases evaluated by immunohistochemistry and in situ hybridization
    Farshid, Gelareh
    Dhatrak, Deepak
    Gilhotra, Amardeep
    Koszyca, Barbara
    Nolan, James
    MODERN PATHOLOGY, 2020, 33 (09) : 1783 - 1790
  • [49] HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma
    Liu, Tieju
    Sun, Baocun
    Zhao, Xiulan
    Gu, Qiang
    Dong, Xueyi
    Yao, Zhi
    Zhao, Nan
    Chi, Jiadong
    Liu, Ning
    Sun, Ran
    Ma, Yuemei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (01) : 116 - 122
  • [50] Immunoexpression of HER2 pathway related markers in HER2 invasive breast carcinomas treated with trastuzumab
    Franco, Andreia Fabiana do Vale
    Malinverni, Andrea Cristina Moraes
    Waitzberg, Angela Flavia Logullo
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 252
12345